Search

Learn about how first-year student get oriented to the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK).

We offer students a fellowship package as well as opportunities to apply for additional funding.

A team of researchers led by Memorial Sloan Kettering physician-scientist Charles L. Sawyers has reported on the preclinical development and early results from the first clinical trial of a promising new drug for prostate cancer.

It's not only what's inside your cells that determines your cancer risk. It's what surrounds them too.

Director, Translational Medicine at Prelude Therapeutics Inc., Wilmington, Delaware